Celcuity appoints ex-Incyte CFO David Gryska to board

By Public Technologies
  • Celcuity appointed David W. Gryska to its board as it shifts to a commercial-stage business following its first FDA approval.
  • Gryska previously served as executive vice president and CFO at Incyte, with earlier CFO roles at Celgene and Scios.
  • He has held board seats across public biotech companies, including a more than 15-year tenure on Seagen’s board.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020800PRIMZONEFULLFEED9838354) on October 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.